About
NMI TT GmbH provides contract research services for pharma and biotech clients in protein profiling, custom cell-based services, and electrophysiology. It also develops microdevice solutions through a separate microdevices business unit. The company is based in Reutlingen, Germany.
Services
Service for Pharma
Non-clinical contract research services offered to pharma and biotech companies through direct contracts, MSAs, and online marketplaces.
Electrophysiology Services
Ion channel-related studies for drug development and other fields, including patch clamp, oocyte recording, live cell imaging, and MEA-based services.
Patch Clamp Services
Manual, automated, and ultra-fast patch clamp services for ion channel studies, compound profiling, and safety assessment.
Manual Patch Clamp Services
Manual whole-cell patch clamp services for compound profiling in cell lines, primary cells, stem cell-derived cells, and tissue slices.
Automated Patch Clamp Services
Automated patch clamp screening based on Sophion QPatch technology for hERG screening and other voltage-gated or ligand-gated targets.
Ultra-Fast Compound Application Services
Ultra-fast compound application for ligand-gated channel studies with millisecond to microsecond solution exchange.
Oocyte Recording
Electrophysiology services using Xenopus oocytes.
Live Cell Imaging
Live-cell imaging used in electrophysiology and cell-based studies.
11 more services
- MEA-Based Services
- Custom Cell Services
- Custom Cell Lines
- CRISPR Cell Lines
- hiPSC Disease Models
- Cell-Based Assays
- Protein Profiling Services
- Simoa® Protein Assay Services
- Luminex Protein Assay Services
- Modified Luminex Beads
- Microdevices
- What to send
- Biopsy material (e.g. skin, blood) from clinically diagnosed individuals for hiPSC model generation
Capabilities
- Assays and studies
- Patch clamp
- High-content imaging
- Cell-based assays
- CRISPR
- Manual patch clamp
- Automated patch clamp
16 more
- Ultra-fast compound application
- MEA
- Live cell imaging
- High-content microscopy
- FACS
- RT-qPCR
- Luminex multiplex immunoassay
- Simoa immunoassay
- Serological assay
- Protein profiling
- Biomarker assay
- CRISPR/Cas9 genome editing
- Oocyte recording
- MEA-based services
- Custom cell lines
- CRISPR cell line
- Scale and capacity
- Up to 10 analytes
- >50 analytes
- 10 million beads per 1 mL
- 4-80 samples
- Therapeutic areas
- Cardiovascular
- CNS
- Pain
- Oncology
- Metabolic diseases
- Neurobiology
7 more
- Neurotox studies
- Drug development
- Safety/tox studies
- Drug-induced organ injury
- Translational research
- Biomarker discovery
- Immuno-oncology
Instruments and platforms
- Quanterix Simoa HD-X
- Quanterix Simoa SP-X
- Sophion QPatch
- QuantStudio platform
- xMAP instruments
- DigiWest
4 more
- Luminex
- Simoa
- RPPA
- MEA microelectrode arrays
Modalities and species
- Modalities
- Small molecule
- Antibody
- Viral vector
- Gene editing
- Species and models
- CHO cells
- TE671 cells
- HEK293 cells
- hiPSC neurons
- Astrocytes
- Xenopus oocytes
12 more
- Primary T cells
- Cell lines
- Primary cells
- Tissue slices
- Oocyte
- hiPSC disease models
- Cell culture
- Tissue
- Plasma
- Serum
- Urine
- CSF
Industries served
- Pharma
- Biotech
- Medical technology
- Academia
Company
- Type
- CRDMO
- Founded
- 2002
- Quality
- FDA guideline S7B (hERG screening and cardiac safety studies) · GCP-compliant conditions (clinical studies) · FDA guidelines (novel Luminex assay development and validation)
Locations
- Address
- Markwiesenstraße 55, 72770 Reutlingen
- Serves
- Worldwide
Contacts
- General enquiry
- info@nmi-tt.de on their site
- Phone
- +49 7121 51530-0